This issue covers initiatives to support continuous education with an article on the impact of a focused oncogenomic course for advanced practitioners (APs). Another article describes the role of APs in managing adverse events of mosunetuzumab in a pivotal phase II study. Two case reports delve into unique adverse event management: one on concurrent ocular and dermatologic toxicities from docetaxel, and another on capecitabine-associated hand-foot syndrome. A Practice Matters article describes a pharmacist-led clinical support program to standardize and improve the care of patients with polycythemia vera.

Read about the process of creating a quick pictorial scale to assess cancer-related fatigue. Another article summarizes targeted melanoma prevention interventions for first-degree relatives of melanoma survivors. Succession planning requires intentional steps by an institution; an article in this issue provides a framework for developing the next generation of AP leaders.